Gain Clarity in Complexity: Transforming Neurodegeneration Research with Biomarker Precision
Event details
Date
Location
Virtual
Introducing Olink® Target 48 Neurodegeneration Panel
Neurodegenerative diseases remain some of medicine’s greatest challenges. Discover Olink’s new biomarker solution—designed to empower scientists with greater precision and confidence as they tackle the complexity of neurodegeneration research.
The new Olink® Target 48 Neurodegeneration panel is the first and only tool to deliver simultaneous, absolute quantification of 42 established and emerging biomarkers—unlocking translational insights that were previously out of reach.
Register here
Join our launch event to see how this innovation can help you:
- Precisely detect and quantify neurodegenerative biomarkers from plasma or CSF in a single scalable assay
- Dive deeper into disease mechanisms with expertly curated content, including emerging and established biomarkers
- Generate robust, reproducible data across studies, sites, and timepoints enabling longitudinal and cross-cohort comparisons
Be among the first to see how this breakthrough can power your neurodegeneration research.
Join the launch!
Speakers
